Data Gaps that Bottleneck Aging Biomarker Discovery — Norn Group
What’s holding back aging biomarkers? Despite growing excitement, most aging biomarkers today remain clinically irrelevant. This piece dives into the real bottleneck: our data. It maps the missing datasets, outlines what’s actually needed for biomarker validation, and proposes a path forward—design
By Marton Meszaros Developing “aging clocks” or “biomarkers of aging” is a popular pursuit within the aging research community, and increasingly also in popular culture. We now have dozens of unverified consumer tests, hundreds of papers worth of research for research’s sake, and some good work that may lead somewhere. The impact of all the work on aging biomarkers today - on clinical care, or on improving the development of therapeutics - is far below what promises to be, and what it could be. In this piece, I make the claim that aging biomarker discovery is bottlenecked in large part by…
saved by
related reading
- Bottlenecks of Aging - Amaranth Foundationamaranth.foundation
- Gap Mapgap-map.org
- What we wish we knew entering the aging fieldlibrariesforthefuture.bio
- What the Aging Field Needs - Celine Haliouacelinehh.com
- Drug Discovery for Menopause with Gero and AthenaBIOathenadao.substack.com
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- Nintil - From chaos, order: On the nature and measurement of biological agingnintil.com
- Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review - PMCncbi.nlm.nih.gov
- Anti-Aging: State of the Art — LessWronglesswrong.com
- A primer on the current state of longevity researchowlposting.com
- The genetic architecture of biological age in nine human organ systems | Nature Agingnature.com
- The Hallmarks of Agingncbi.nlm.nih.gov